Viracta Therapeutics
VIRX
#10344
Rank
A$1.05 M
Marketcap
$0.02658
Share price
-16.26%
Change (1 day)
-97.88%
Change (1 year)

Earnings for Viracta Therapeutics (VIRX)

Earnings in 2024 (TTM): -A$64.18 Million

According to Viracta Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$79.83 Million a decrease over its 2022 earnings that were of -A$76.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viracta Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$64.18 Million-19.61%
2023 -A$79.83 Million3.78%
2022 -A$76.92 Million-57.13%
2021 -A$0.18 Billion503.47%
2020 -A$29.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.23 Billion 230.10%๐Ÿ‡บ๐Ÿ‡ธ USA